National Cancer Institute (NCI) – SBIR Funding Opportunities Available
NCI is currently soliciting proposal for two contract funding opportunities in cancer nanotechnology through the SBIR & STTR Programs:
- Therapeutics and Theranostics Based on Nanotechnology
Contract Number: PHS 2011-1/300
Deadline for submission: November 8, 2010 by 5 p.m. EST
IPart Electronic Pre-Proposal MUST be Submitted by Monday, October 11, 2010 to receive a technical review and consideration for IPart support.
- Nanotechnology Sensing Platforms for Improved Diagnosis of Cancer
Contract Number: PHS 2011-1/301
Deadline for submission: November 8, 2010 by 5 p.m. EST
IPart Electronic Pre-Proposal MUST be Submitted by Monday, October 11, 2010 to receive a technical review and consideration for IPart support.
In addition, the NCI is announcing a new funding opportunity for small businesses using the U43/U44 mechanism to develop new, or to improve existing applications of nanotechnology-based therapeutics or in vivo diagnostics:
- Cancer Diagnostic and Therapeutic Agents Enabled by Nanotechnology [SBIR (U43/U44)]
Program Announcement Number: PAR-10-286
First deadline for submission: December 7, 2010
IPart Electronic Pre-Proposal MUST be Submitted by Tuesday, November 9, 2010 to receive a technical review and consideration for IPart support.
Learn more about cancer nanotechnology funding opportunities at:http://nano.cancer.gov/collaborate/funding/.
To learn more about the NCI SBIR Program, benefits to applying, and eligibility criteria, visit: www.sbir.cancer.gov.
